|
CHCHD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.146800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.720400E-01 |
| Normal-vs-Stage2 |
6.016400E-01 |
| Normal-vs-Stage3 |
9.601200E-03 |
| Normal-vs-Stage4 |
5.404200E-01 |
| Stage1-vs-Stage2 |
5.601600E-01 |
| Stage1-vs-Stage3 |
7.636600E-03 |
| Stage1-vs-Stage4 |
5.152600E-01 |
| Stage2-vs-Stage3 |
1.720830E-01 |
| Stage2-vs-Stage4 |
8.749600E-01 |
| Stage3-vs-Stage4 |
3.214000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.294400E-01 |
| Normal-vs-AfricanAmerican |
2.601600E-01 |
| Normal-vs-Asian |
9.083400E-01 |
| Caucasian-vs-AfricanAmerican |
2.968200E-01 |
| Caucasian-vs-Asian |
9.460400E-01 |
| AfricanAmerican-vs-Asian |
7.566800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.287200E-01 |
| Normal-vs-Female |
1.670400E-01 |
| Male-vs-Female |
1.433210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.376800E-01 |
| Normal-vs-Extreme_Weight |
6.099400E-01 |
| Normal-vs-Obese |
5.900600E-01 |
| Normal-vs-Extreme_Obese |
2.007500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.319620E-01 |
| Normal_Weight-vs-Obese |
5.327600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.218600E-01 |
| Extreme_Weight-vs-Obese |
3.307400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.487760E-02 |
| Obese-vs-Extreme_Obese |
1.912180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.346050E-01 |
| Normal-vs-Age(41-60Yrs) |
7.618200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.784600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.517250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.814400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.135600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.565800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.509000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.655020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.360500E-02 |
| Normal-VS-Type2 PRCC |
3.56899999998106E-06 |
| Normal-VS-KIRP CIMP |
1.014160E-02 |
| Normal-VS-Unclassified PRCC |
1.215400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.74715797385261E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.598800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.920300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.80699999986179E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.019900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.459900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.889580E-02 |
| Normal-vs-N1 |
3.020100E-02 |
| Normal-vs-N2 |
8.418000E-01 |
| N0-vs-N1 |
8.008600E-01 |
| N0-vs-N2 |
4.219000E-01 |
| N1-vs-N2 |
4.200800E-01 |
|
|
